Arcturus was founded and is led by Joseph E. Payne, President and Chief Executive Officer. Mr. Payne has over twenty years of drug discovery experience at Arcturus, Merck Research Labs, DuPont Pharmaceuticals Co., Bristol-Myers Squibb Co., Kalypsys Inc., and Nitto Denko Corporation. He has contributed to over 40 publications and patents, and several IND clinical candidates.
At Arcturus, he is pioneering efforts to develop RNA technologies and novel RNA therapeutics for rare, infectious, fibrotic, and respiratory diseases with large unmet medical needs. Arcturus has two proprietary technologies with the potential to address the major hurdles in RNA medicine development such as RNA delivery challenges, limited potency and narrow therapeutic index.